The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Stratification of risk for patients with prostate cancer at biopsy using CCP score.
Neal D. Shore
No relevant relationships to disclose
Brian Abbott
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Raoul S. Concepcion
No relevant relationships to disclose
Daniel Saltzstein
No relevant relationships to disclose
Rajesh R. Kaldate
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Kelsey Moyes
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Arletta van Breda
No relevant relationships to disclose
Christopher Clark
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Jennifer Saam
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics
Michael K. Brawer
Employment or Leadership Position - Myriad Genetics
Stock Ownership - Myriad Genetics